Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SeqLL
Billerica, Massachusetts, United Statesseqll.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
SeqLL commercializes the tSMS platform for direct single-molecule RNA and DNA sequencing. The technology enables high precision quantification from small or degraded samples. The company supports research applications including biomarker discovery, diagnostic assay development, epigenetics, chromatin biology, and more through collaborations with academic institutions and government agencies. No clinical trial results as it does not develop drugs.
- Modalities
- DeviceService
- Industry
- Molecular Diagnostics
02
Partnerships
U.S. Department of Justice's Federal Bureau of Investigation (FBI) – forensic capabilities evaluation using tSMS platformTrue Bearing Diagnostics – whole-blood RNA analysis for coronary artery disease biomarkers using tSMSThe Bernstein Laboratory – chromatin biology/epigenetic regulation research collaborationThe Ting Laboratory – single-molecule technologies collaborationThe Jackson Laboratory for Genomic Medicine – chromatin interaction analysis methods development with single-molecule resolutionWeizmann Institute of Science – innovative single-molecule technologies development/applicationTetracore Inc. – provision of tSMS systems/support
Beyond the preview
Go deeper on SeqLL.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SeqLL.